Lv625
1618 积分 2025-07-22 加入
Strengthening Alcohol Risk Reduction Strategies Through Integrated Approaches: A Critical Appraisal
1个月前
已完结
Prognostic value of the neutrophil percentage-to-albumin ratio for all-cause and cardiovascular disease mortality in individuals with coronary heart disease: A cohort study
1个月前
已关闭
SGLT2 inhibitor empagliflozin downregulates miRNA-34a-5p and targets GREM2 to inactivate hepatic stellate cells and ameliorate non-alcoholic fatty liver disease-associated fibrosis
5个月前
已完结
SGLT2 inhibition and adipose tissue metabolism: current outlook and perspectives
5个月前
已关闭
Increased Liver Localization of Lipopolysaccharides in Human and Experimental NAFLD
5个月前
已完结
Dapagliflozin exerts anti-inflammatory effects via inhibition of LPS-induced TLR-4 overexpression and NF-κB activation in human endothelial cells and differentiated macrophages
5个月前
已完结
SGLT-2 inhibitors and GLP-1 receptor agonists in metabolic dysfunction-associated fatty liver disease
5个月前
已完结
Lipotoxicity and the gut-liver axis in NASH pathogenesis
5个月前
已完结
Global prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus: an updated systematic review and meta-analysis
6个月前
已完结
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis
6个月前
已完结
皖公网安备34019202002308
